DOCS Doximity, Inc. Class A Common Stock
حول Doximity, Inc. Class A Common Stock نظرة عامة على الشركة من ويكيبيديا
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
اقرأ المزيد
Doximity is an online networking service for medical professionals. Launched in 2010, the platform offers its members curated medical news, telehealth tools, and case collaboration.
The company is based in San Francisco.
History
The company was launched in March 2011 by co-founders Nate Gross, Jeff Tangney and Shari Buck.
In 2013, founder Jeff Tangney remained CEO while the company was based in San Mateo, California.
By 2013, it became one of the largest networks for U.S. healthcare professionals, with approximately 10 percent of U.S. doctors as members.
By the beginning of 2014, 40 percent of U.S. physicians became members. In 2016, it began offering a free service for doctors to call patients using their work number on their mobile phones. In 2018, the company announced that it had reached 1 million members, accounting for more than 70 percent of U.S. physicians. In 2021, Doximity served more than 2 million registered members, including over 80 percent of U.S. physicians and over 50 percent of nurse practitioners and physician assistants.
In 2016, the company was ranked #6 on the Deloitte Technology Fast 500 list.
In November 2019, Doximity was listed on the Deloitte Technology Fast 500 list for the fourth consecutive year.
In May 2020, the company added video. Dialer Video, a video telehealth app, allows physicians to video call patients through personal smartphones.
In June 2020, Doximity Acquires THMED and launches the Curative Brand. Curative is a staffing and recruiting company offering permanent and Locum/Temporary placement services.
In May 2021, Doximity, a professional network for physicians with telehealth and scheduling tools, filed for an initial public offering (IPO) seeking to raise $100 million. Morgan Stanley, Goldman Sachs and J.P. Morgan Securities were the lead underwriters for the IPO. Doximity raised nearly $606 million in its IPO. In its June 2021 IPO on the NYSE, gave it a market cap shortly after its debut of $9.4 billion.
In 2021 August, CNBC reported that the site's news feed was "inundated" with vaccine misinformation shared among physicians, despite Doximity's community guidelines banning medical misinformation. AT the time, 80% of its revenue came from ads paid by pharmaceutical firms and hospitals, and directed at physicians on the site.
In November 2023, Doximity released DocDefender, a free service that removed a physician's personal phone numbers and addresses from public websites. Doximity continued to be used by around 80% of US doctors.
Investors
In April 2014, the company announced it had raised a $54 million financing round led by the venture capital firm Draper Fisher Jurvetson and the mutual fund company T. Rowe Price. Morgan Stanley Investment Management also invested. This investment brought Doximity's total funding to $81 million.
Doximity received $10.8 million in venture capital funding from Emergence Capital Partners and Interwest Partners in March 2011, and $17 million in Series B funding led by Morgenthaler Ventures in September 2012.
Products and services
Dialer
In 2016, Doximity built Dialer, a free communication tool for physicians to call their patients. The Doximity Dialer app allows physicians to call patients from their personal cell phone, and the patient sees the doctor's office number on caller ID.
Dialer Video
In May 2020, Doximity released Dialer Video, a telemedicine tool that allows physicians to video call their patients directly from their own smartphones.
In July 2020, Doximity said that more than 100,000 U.S. Doctors use Dialer Video, its telemedicine app.
Acquisition
In June 2020, Doximity acquired THMED, a healthcare company. Following the purchase, THMED changed its name to Curative and started concentrating on customized medical-personnel queries.
In February 2022, Doximity acquired Amion, an on-call doctor scheduling company.
In August 2025, Doximity acquired Pathway Medical, a Canadian startup specializing in medical AI and evidence-based clinical reference tools.
المصدر: ويكيبيديا (الإنجليزية), CC BY-SA 4.0 · عرض على ويكيبيديا ↗
DOCS لقطة سريعة للسهم السعر، القيمة السوقية، مكرر الربحية (P/E)، ربحية السهم (EPS)، العائد على حقوق الملكية (ROE)، نسبة الدين إلى حقوق الملكية، نطاق 52 أسبوعًا
DOCS مخطط سعر السهم OHLCV يومي مع مؤشرات فنية — تحريك وتكبير وتخصيص عرضك
أداء 10 سنوات اتجاهات الإيرادات وصافي الدخل والهوامش وربحية السهم
التقييم نسب مكرر الربحية (P/E)، مكرر المبيعات (P/S)، مكرر القيمة الدفترية (P/B)، EV/EBITDA — هل السهم مرتفع السعر أم رخيص؟
الربحية هامش الربح الإجمالي والتشغيلي والصافي؛ العائد على حقوق الملكية (ROE)، العائد على الأصول (ROA)، العائد على رأس المال المستثمر (ROIC)
الصحة المالية الديون، السيولة، الملاءة المالية — قوة الميزانية العمومية
النمو نمو الإيرادات وربحية السهم وصافي الدخل: مقارنة بالعام السابق (YoY)، متوسط النمو السنوي المركب لـ 3 سنوات (3Y CAGR)، متوسط النمو السنوي المركب لـ 5 سنوات (5Y CAGR)
كفاءة رأس المال معدل دوران الأصول، معدل دوران المخزون، معدل دوران المستحقات
DOCS توافق الآراء التحليلي آراء المحللين الصعودية والهبوطية، السعر المستهدف لمدة 12 شهرًا، الصعود
- شراء قوي 5 17,9%
- شراء 9 32,1%
- احتفاظ 13 46,4%
- بيع 1 3,6%
- بيع قوي 0 0,0%
السعر المستهدف لمدة 12 شهرًا
17 محللين · 2026-08-15سجل الأرباح ربحية السهم الفعلية مقابل التقديرات، نسبة المفاجأة %، معدل التجاوز، تاريخ الأرباح التالي
| الفترة | EPS Actual | EPS المتوقع | المفاجأة |
|---|---|---|---|
| 30 يونيو، 2026 | $0.29 | $0.31 | -0.02% |
| 31 مارس، 2026 | $0.26 | $0.29 | -0.03% |
| 31 ديسمبر، 2025 | $0.46 | $0.45 | 0.01% |
| 30 سبتمبر، 2025 | $0.45 | $0.39 | 0.06% |
| 30 يونيو، 2025 | $0.36 | $0.31 | 0.05% |
| 31 مارس، 2025 | $0.46 | $0.45 | 0.01% |
مقارنة الأقران (الصناعة الفرعية GICS) المقاييس الرئيسية مقابل أقران القطاع
| الرمز | القيمة السوقية | P/E | الإيرادات سنويًا | هامش الربح الصافي | ROE | هامش الربح الإجمالي |
|---|---|---|---|---|---|---|
| DOCS | $4.27B | 23.8 | 13.1% | 30.4% | 19.2% | 89.1% |
| VEEV | $33.40B | 37.5 | 16.3% | 28.4% | 13.1% | 75.5% |
| WAY | $6.27B | 53.7 | 16.5% | 10.2% | 3.2% | — |
| HTFL | $2.49B | -9.2 | 39.9% | -66.3% | 39.3% | 76.8% |
| SDGR | — | -12.7 | 23.3% | -40.4% | -29.2% | 55.7% |
| GDRX | — | 30.1 | 0.57% | 3.8% | 4.8% | — |
| CERT | $1.40B | -881.0 | 8.8% | -0.38% | -0.15% | — |
| TDOC | $1.25B | -6.1 | -1.5% | -7.9% | -14.3% | — |
| HSTM | $682M | 37.8 | 4.3% | 6.0% | 5.2% | — |
| PHR | — | 335.8 | 14.5% | 0.48% | 0.73% | — |
| CTEV | $708M | -2.5 | 3.7% | -29.4% | 265.9% | — |
الأساسيات الكاملة جميع المقاييس حسب السنة — قائمة الدخل، الميزانية العمومية، التدفق النقدي
قائمة الدخل 16
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $645M | $570M | $475M | $419M | $344M | $207M | $116M | |
| Cost of Revenue | $70M | $56M | $51M | $53M | $40M | $31M | $15M | |
| Gross Profit | $575M | $515M | $425M | $366M | $304M | $176M | $101M | |
| R&D Expense | $131M | $93M | $82M | $80M | $62M | $44M | $32M | |
| SG&A Expense | $65M | $46M | $38M | $37M | $36M | $16M | $7M | |
| Operating Expenses | $360M | $287M | $261M | $240M | $190M | $122M | $79M | |
| Operating Income | $215M | $228M | $164M | $125M | $114M | $53M | $22M | |
| Other Non-op | $-806.0K | $-247.0K | $62.0K | $-146.0K | $-448.0K | $4M | $1M | |
| Pretax Income | $250M | $264M | $185M | $133M | $114M | $58M | $24M | |
| Income Tax | $54M | $40M | $38M | $20M | $-41M | $8M | $-6M | |
| Net Income | $196M | $223M | $148M | $113M | $155M | $50M | $30M | |
| EPS (Basic) | $1.05 | $1.19 | $0.78 | $0.58 | $0.82 | $0.29 | $0.16 | |
| EPS (Diluted) | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 | $0.23 | $0.13 | |
| Shares (Basic) | 187,014,000 | 186,841,000 | 190,172,000 | 193,176,000 | 163,484,000 | 74,342,000 | 66,758,000 | |
| Shares (Diluted) | 199,048,000 | 201,208,000 | 205,734,000 | 213,425,000 | 191,017,000 | 95,134,000 | 81,710,000 | |
| EBITDA | $229M | $238M | $174M | $135M | $119M | · | · |
الميزانية العمومية 24
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $219M | $210M | $97M | $158M | $113M | $66M | · | |
| Receivables | $145M | $128M | $101M | $107M | $81M | $50M | · | |
| Prepaid Expense | $51M | $45M | $49M | $27M | $19M | $11M | · | |
| Current Assets | $944M | $1.09B | $913M | $975M | $904M | $209M | · | |
| PP&E (Net) | $18M | $14M | $12M | $11M | $8M | $8M | · | |
| PP&E (Gross) | $49M | $39M | $31M | $25M | $17M | $12M | · | |
| Accum. Depreciation | $31M | $25M | $19M | $14M | $8M | $5M | · | |
| Goodwill | $85M | $68M | $68M | $68M | $19M | $19M | · | |
| Intangibles | $35M | $23M | $27M | $32M | $8M | $10M | · | |
| Other Non-current Assets | $2M | $2M | $1M | $2M | $2M | $3M | · | |
| Total Assets | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Accounts Payable | $4M | $1M | $2M | $1M | $463.0K | $2M | · | |
| Accrued Liabilities | $43M | $38M | $44M | $31M | $25M | $16M | · | |
| Current Liabilities | $155M | $156M | $147M | $140M | $111M | $102M | · | |
| Capital Leases | $8M | $10M | $12M | $14M | $447.0K | $284.0K | · | |
| Other Non-current Liabilities | $9M | $9M | $7M | $1M | $956.0K | $972.0K | · | |
| Total Liabilities | $173M | $182M | $178M | $171M | $113M | $104M | · | |
| Common Stock | $183.0K | $189.0K | $187.0K | $194.0K | $192.0K | $83.0K | · | |
| Paid-in Capital | $1.00B | $894M | $824M | $762M | $703M | $30M | · | |
| Retained Earnings | $-51M | $187M | $80M | $218M | $191M | $36M | · | |
| AOCI | $28.0K | $1M | $-3M | $-14M | $-15M | $-21.0K | · | |
| Stockholders' Equity | $951M | $1.08B | $901M | $966M | $879M | $67M | $1M | |
| Liabilities + Equity | $1.12B | $1.26B | $1.08B | $1.14B | $991M | $252M | · | |
| Shares Outstanding | 183,060,000 | 188,875,000 | 186,562,000 | 193,941,000 | 192,398,000 | 82,910,000 | · |
التدفق النقدي 15
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| D&A | $14M | $11M | $10M | $10M | $5M | $4M | $900.0K | |
| Stock-based Comp | $122M | $72M | $51M | $48M | $31M | $7M | $2M | |
| Deferred Tax | $32M | $-12M | $-9M | $13M | $-41M | $5M | $-7M | |
| Amort. of Intangibles | $6M | $4M | $5M | $5M | $1M | $1M | $0 | |
| Restructuring | · | $2M | $8M | $0 | $0 | · | · | |
| Other Non-cash | $-38M | $-21M | $-16M | $-5M | $-23M | · | · | |
| Operating Cash Flow | $326M | $273M | $184M | $180M | $127M | $83M | $26M | |
| CapEx | $0 | $0 | $147.0K | $2M | $2M | $245.0K | $285.0K | |
| Investing Cash Flow | $147M | $-29M | $31M | $-60M | $-641M | $-70M | $-13M | |
| Stock Repurchased | $432M | $120M | $281M | $85M | $3M | $2M | $0 | |
| Net Stock Activity | $-432M | $-120M | $-281M | $-85M | $-3M | · | · | |
| Financing Cash Flow | $-464M | $-131M | $-277M | $-74M | $560M | $5M | $2M | |
| Net Change in Cash | $10M | $113M | $-61M | $45M | $46M | $18M | $15M | |
| Taxes Paid | $22M | · | · | · | · | · | · | |
| Free Cash Flow | $326M | $273M | $184M | $178M | $125M | · | · |
الربحية 8
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Gross Margin | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% | · | · | |
| Operating Margin | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% | · | · | |
| Net Margin | 30.4% | 39.1% | 31.0% | 26.9% | 45.1% | · | · | |
| Pretax Margin | 38.8% | 46.2% | 39.0% | 31.8% | 33.2% | · | · | |
| EBITDA Margin | 35.6% | 41.8% | 36.6% | 32.3% | 34.5% | · | · | |
| ROA | 16.4% | 19.1% | 13.3% | 10.6% | 24.9% | · | · | |
| ROE | 19.2% | 21.1% | 16.7% | 11.9% | 18.0% | · | · | |
| ROIC | 17.7% | 17.8% | 14.5% | 11.0% | 17.5% | · | · |
السيولة والملاءة 2
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 | · | · | |
| Quick Ratio | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 | · | · |
الكفاءة 2
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.5 | 0.5 | 0.4 | 0.4 | 0.6 | · | · | |
| Receivables Turnover | 4.7 | 5.0 | 4.6 | 4.5 | 5.2 | · | · |
معدلات النمو 9
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue YoY | 13.1% | 20.0% | 13.5% | 22.0% | 66.0% | · | · | |
| Revenue CAGR 3Y | 15.4% | 18.4% | 32.0% | · | · | · | · | |
| Revenue CAGR 5Y | 25.5% | · | · | · | · | · | · | |
| EPS YoY | -11.7% | 54.2% | 35.9% | -24.3% | 204.3% | · | · | |
| EPS CAGR 3Y | 22.7% | 16.6% | 46.3% | · | · | · | · | |
| EPS CAGR 5Y | 33.6% | · | · | · | · | · | · | |
| Net Income YoY | -12.2% | 51.2% | 30.8% | -27.1% | 208.3% | · | · | |
| Net Income CAGR 3Y | 20.2% | 13.0% | 43.2% | · | · | · | · | |
| Net Income CAGR 5Y | 31.3% | · | · | · | · | · | · |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | 2026 | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $645M | $570M | $475M | $419M | $344M | · | · | |
| Net Income TTM | $196M | $223M | $148M | $113M | $155M | · | · | |
| Market Cap | $4.27B | $10.96B | $5.02B | $6.28B | $10.02B | · | · | |
| P/E | 23.8 | 52.3 | 37.4 | 61.1 | 74.4 | · | · | |
| P/S | 6.6 | 19.2 | 10.6 | 15.0 | 29.2 | · | · | |
| P/B | 4.5 | 10.1 | 5.6 | 6.5 | 11.4 | · | · | |
| P / Tangible Book | 5.1 | 11.1 | 6.2 | 7.2 | 11.8 | · | · | |
| P / Cash Flow | 13.1 | 40.1 | 27.3 | 35.0 | 79.2 | · | · | |
| P / FCF | 13.1 | 40.1 | 27.3 | 35.3 | 80.4 | · | · | |
| Earnings Yield | 4.2% | 1.9% | 2.7% | 1.6% | 1.3% | · | · |
قائمة الدخل 16
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $157M | $145M | $185M | $169M | $146M | $138M | $169M | $137M | $127M | $118M | $135M | $114M | $108M | $111M | $115M | $102M | |
| Cost of Revenue | $24M | $19M | $19M | $16M | $16M | $14M | $14M | $14M | $14M | $13M | $12M | $13M | $13M | $14M | $14M | $13M | |
| Gross Profit | $133M | $126M | $166M | $152M | $130M | $124M | $154M | $123M | $113M | $105M | $123M | $101M | $95M | $97M | $102M | $89M | |
| R&D Expense | $38M | $39M | $35M | $30M | $27M | $25M | $22M | $23M | $23M | $20M | $20M | $20M | $22M | $22M | $21M | $19M | |
| SG&A Expense | $16M | $16M | $18M | $19M | $12M | $13M | $14M | $10M | $9M | $10M | $10M | $9M | $9M | $10M | $10M | $9M | |
| Operating Expenses | $99M | $101M | $94M | $88M | $76M | $75M | $74M | $70M | $67M | $64M | $65M | $67M | $66M | $64M | $63M | $57M | |
| Operating Income | $34M | $25M | $72M | $64M | $55M | $49M | $80M | $53M | $46M | $42M | $59M | $34M | $30M | $33M | $38M | $32M | |
| Other Non-op | $-286.0K | $-235.0K | $-158.0K | $-178.0K | $-235.0K | $-51.0K | $-30.0K | $-114.0K | $-52.0K | $73.0K | $-55.0K | $-50.0K | $94.0K | $-27.0K | $-25.0K | $-48.0K | |
| Pretax Income | $40M | $32M | $81M | $73M | $64M | $58M | $90M | $62M | $53M | $48M | $63M | $40M | $35M | $37M | $41M | $33M | |
| Income Tax | $16M | $13M | $19M | $11M | $11M | $-4M | $15M | $18M | $12M | $7M | $15M | $9M | $6M | $6M | $7M | $7M | |
| Net Income | $24M | $19M | $62M | $62M | $53M | $62M | $75M | $44M | $41M | $41M | $48M | $31M | $28M | $31M | $33M | $26M | |
| EPS (Basic) | $0.13 | $0.11 | $0.33 | $0.33 | $0.28 | $0.33 | $0.40 | $0.24 | $0.22 | $0.21 | $0.26 | $0.16 | $0.15 | $0.15 | $0.17 | $0.14 | |
| EPS (Diluted) | $0.13 | $0.09 | $0.31 | $0.31 | $0.27 | $0.31 | $0.37 | $0.22 | $0.21 | $0.20 | $0.24 | $0.15 | $0.13 | $0.15 | $0.16 | $0.12 | |
| Shares (Basic) | 182,569,000 | -376,153,000 | 187,478,000 | 187,705,000 | 187,984,000 | -372,182,000 | 187,161,000 | 186,252,000 | 185,610,000 | -383,770,000 | 186,309,000 | 193,112,000 | 194,521,000 | -385,713,000 | 192,805,000 | 193,137,000 | |
| Shares (Diluted) | 191,169,000 | -402,079,000 | 199,224,000 | 200,745,000 | 201,158,000 | -400,656,000 | 202,233,000 | 200,407,000 | 199,224,000 | -416,098,000 | 200,463,000 | 209,014,000 | 212,355,000 | -427,543,000 | 212,065,000 | 213,949,000 | |
| EBITDA | $38M | · | $72M | $64M | $57M | · | $80M | $53M | $49M | · | $59M | $34M | $32M | · | $38M | $32M |
الميزانية العمومية 24
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | $274M | $219M | $65M | $169M | $137M | $210M | $165M | $184M | $111M | $97M | $123M | $108M | $307M | · | $136M | $74M | |
| Receivables | $178M | $145M | $157M | $129M | $142M | $128M | $138M | $125M | $121M | $101M | $98M | $97M | $93M | · | $75M | $79M | |
| Prepaid Expense | $49M | $51M | $102M | $85M | $52M | $45M | $30M | $27M | $37M | $49M | $27M | $33M | $20M | · | $17M | $16M | |
| Current Assets | $914M | $944M | $993M | $1.09B | $1.03B | $1.09B | $1.01B | $958M | $908M | $913M | $841M | $863M | $990M | · | $899M | $848M | |
| PP&E (Net) | $19M | $18M | $17M | $16M | $14M | $14M | $13M | $13M | $13M | $12M | $12M | $12M | $12M | · | $12M | $12M | |
| PP&E (Gross) | $53M | $49M | $47M | $43M | $41M | $39M | $37M | $35M | $33M | $31M | $29M | $28M | $26M | · | $24M | $22M | |
| Accum. Depreciation | $34M | $31M | $30M | $28M | $26M | $25M | $23M | $22M | $21M | $19M | $18M | $16M | $15M | · | $12M | $11M | |
| Goodwill | $85M | $85M | $85M | $85M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | $68M | · | $68M | $68M | |
| Intangibles | $33M | $35M | $37M | $39M | $22M | $23M | $24M | $25M | $26M | $27M | $28M | $29M | $31M | · | $33M | $34M | |
| Other Non-current Assets | $2M | $2M | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $2M | $2M | $1M | · | $1M | $1M | |
| Total Assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Accounts Payable | $6M | $4M | $5M | $4M | $2M | $1M | $2M | $3M | $2M | $2M | $2M | $714.0K | $582.0K | · | $2M | $1M | |
| Accrued Liabilities | $33M | · | $77M | $34M | $38M | $38M | $43M | $34M | $28M | $44M | $34M | $29M | $32M | · | $33M | $26M | |
| Current Liabilities | $150M | $155M | $150M | $140M | $160M | $156M | $116M | $132M | $135M | $147M | $105M | $123M | $133M | · | $106M | $118M | |
| Capital Leases | $8M | $8M | $9M | $9M | $10M | $10M | $11M | $11M | $12M | $12M | $13M | $13M | $14M | · | $14M | $15M | |
| Other Non-current Liabilities | $10M | $9M | $19M | $12M | $9M | $9M | $9M | $8M | $7M | $7M | $841.0K | $7M | $6M | · | $1M | $1M | |
| Total Liabilities | $168M | $173M | $178M | $162M | $179M | $182M | $141M | $157M | $160M | $178M | $136M | $154M | $163M | · | $137M | $149M | |
| Common Stock | $180.0K | $183.0K | $185.0K | $188.0K | $187.0K | $189.0K | $188.0K | $187.0K | $186.0K | $187.0K | $186.0K | $188.0K | $195.0K | · | $193.0K | $192.0K | |
| Paid-in Capital | $1.04B | $1.00B | $957M | $936M | $907M | $894M | $879M | $863M | $841M | $824M | $808M | $795M | $778M | · | $746M | $731M | |
| Retained Earnings | $-119M | $-51M | $21M | $158M | $117M | $187M | $151M | $95M | $73M | $80M | $61M | $85M | $225M | · | $203M | $170M | |
| AOCI | $-348.0K | $28.0K | $1M | $1M | $1M | $1M | $1M | $3M | $-1M | $-3M | $-5M | $-9M | $-12M | · | $-19M | $-22M | |
| Stockholders' Equity | $916M | $951M | $979M | $1.10B | $1.03B | $1.08B | $1.03B | $961M | $914M | $901M | $865M | $871M | $991M | $966M | $930M | $879M | |
| Liabilities + Equity | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | $1.26B | $1.17B | $1.12B | $1.07B | $1.08B | $1.00B | $1.03B | $1.15B | · | $1.07B | $1.03B | |
| Shares Outstanding | 179,849,000 | 183,060,000 | 184,992,000 | 188,090,000 | 187,453,000 | 188,875,000 | 187,584,000 | 186,781,000 | 185,704,000 | 186,562,000 | 186,175,000 | 188,518,000 | 194,649,000 | 193,941,000 | 193,252,000 | 192,302,000 |
التدفق النقدي 15
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D&A | $4M | $4M | $4M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | $3M | |
| Stock-based Comp | $37M | $37M | $34M | $29M | $22M | $18M | $19M | $18M | $17M | $12M | $12M | $13M | $14M | $13M | $14M | $11M | |
| Deferred Tax | · | $32M | $0 | · | · | $-14M | $2M | · | · | $-9M | $0 | $0 | $0 | $4M | $9M | $0 | |
| Amort. of Intangibles | $2M | $2M | $2M | $2M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | $1M | |
| Restructuring | · | · | · | · | · | $0 | $0 | $2M | · | $0 | $0 | $8M | · | $0 | $0 | $0 | |
| Other Non-cash | $-23M | · | · | · | $-16M | · | · | · | $-20M | · | · | · | $12M | · | · | · | |
| Operating Cash Flow | $42M | $110M | $61M | $94M | $62M | $98M | $65M | $68M | $41M | $64M | $50M | $13M | $57M | $47M | $49M | $40M | |
| CapEx | $62.0K | · | · | · | $0 | $0 | $0 | $0 | $0 | $0 | $36.0K | $41.0K | $70.0K | $21.0K | $204.0K | $766.0K | |
| Investing Cash Flow | $113M | $138M | $38M | $-32M | $3M | $-24M | $-59M | $24M | $30M | $-76M | $40M | $-50M | $117M | $-13M | $13M | $-19M | |
| Stock Repurchased | $92M | $91M | $197M | $22M | $122M | $27M | $19M | $23M | $51M | $18M | $77M | $164M | $22M | $15M | $0 | $61M | |
| Net Stock Activity | $-92M | · | · | · | $-122M | · | · | · | $-51M | · | · | · | $-22M | · | · | · | |
| Financing Cash Flow | $-101M | $-93M | $-204M | $-30M | $-137M | $-30M | $-25M | $-20M | $-57M | $-14M | $-76M | $-161M | $-26M | $-12M | $779.0K | $-57M | |
| Net Change in Cash | $54M | $154M | $-104M | $32M | $-72M | $44M | $-19M | $73M | $15M | $-26M | $15M | $-198M | $149M | $22M | $63M | $-36M | |
| Taxes Paid | · | · | · | · | · | · | $14M | $9M | $13M | · | $9M | $29M | $0 | · | $2M | · | |
| Free Cash Flow | $42M | · | · | · | · | · | · | · | $41M | · | · | · | $57M | · | · | · |
الربحية 8
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 84.9% | · | 89.9% | 90.2% | 89.2% | · | 91.6% | 90.0% | 89.3% | · | 91.0% | 88.8% | 87.9% | · | 88.3% | 87.1% | |
| Operating Margin | 21.5% | · | 38.9% | 37.8% | 37.4% | · | 47.4% | 38.8% | 36.4% | · | 43.3% | 29.7% | 27.4% | · | 33.4% | 31.4% | |
| Net Margin | 15.5% | · | 33.3% | 36.8% | 36.5% | · | 44.6% | 32.3% | 32.7% | · | 35.4% | 26.9% | 26.2% | · | 29.0% | 25.7% | |
| Pretax Margin | 25.8% | · | 43.7% | 43.3% | 44.0% | · | 53.3% | 45.4% | 42.0% | · | 46.6% | 34.9% | 31.8% | · | 35.5% | 32.3% | |
| EBITDA Margin | 24.2% | · | 38.9% | 37.8% | 39.3% | · | 47.4% | 38.8% | 38.4% | · | 43.3% | 29.7% | 29.8% | · | 33.4% | 31.4% | |
| ROA | 2.1% | · | 5.3% | 5.2% | 4.7% | · | 6.9% | 4.1% | 3.7% | · | 4.6% | 3.0% | 2.6% | · | 3.4% | 2.8% | |
| ROE | 2.5% | · | 6.1% | 6.0% | 5.5% | · | 7.9% | 4.8% | 4.3% | · | 5.3% | 3.5% | 3.0% | · | 3.8% | 3.2% | |
| ROIC | 2.2% | · | 5.6% | 5.0% | 4.4% | · | 6.5% | 3.9% | 3.9% | · | 5.1% | 3.0% | 2.5% | · | 3.4% | 2.9% |
السيولة والملاءة 2
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 6.1 | · | 6.6 | 7.8 | 6.5 | · | 8.7 | 7.2 | 6.7 | · | 8.0 | 7.0 | 7.5 | · | 8.5 | 7.2 | |
| Quick Ratio | 3.0 | · | 1.5 | 2.1 | 1.7 | · | 2.6 | 2.3 | 1.7 | · | 2.1 | 1.7 | 3.0 | · | 2.0 | 1.3 |
الكفاءة 2
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Asset Turnover | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.2 | 0.1 | 0.1 | · | 0.1 | 0.1 | 0.1 | · | 0.1 | 0.1 | |
| Receivables Turnover | 1.0 | · | 1.3 | 1.3 | 1.1 | · | 1.4 | 1.2 | 1.2 | · | 1.6 | 1.3 | 1.3 | · | 1.6 | 1.5 |
التقييم (آخر 12 شهرًا) 10
| المقياس | اتجاه | Q1 2027 | Q4 2026 | Q3 2026 | Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue TTM | $656M | · | $668M | $620M | $578M | · | $567M | $512M | $484M | · | $473M | $440M | $417M | · | $406M | $370M | |
| Net Income TTM | $201M | · | $252M | $235M | $214M | · | $209M | $164M | $148M | · | $140M | $119M | $111M | · | $138M | $140M | |
| Market Cap | $3.73B | · | $8.19B | $13.76B | $11.50B | · | $10.02B | $8.14B | $5.19B | · | $5.22B | $4.00B | $6.62B | · | $6.49B | $5.81B | |
| P/E | 20.3 | · | 35.1 | 62.5 | 57.3 | · | 51.3 | 53.1 | 38.3 | · | 41.2 | 37.9 | 66.7 | · | 52.4 | 46.5 | |
| P/S | 5.7 | · | 12.3 | 22.2 | 19.9 | · | 17.7 | 15.9 | 10.7 | · | 11.0 | 9.1 | 15.9 | · | 16.0 | 15.7 | |
| P/B | 4.1 | · | 8.4 | 12.6 | 11.2 | · | 9.7 | 8.5 | 5.7 | · | 6.0 | 4.6 | 6.7 | · | 7.0 | 6.6 | |
| P / Tangible Book | 4.7 | · | 9.6 | 14.2 | 12.3 | · | 10.7 | 9.4 | 6.3 | · | 6.8 | 5.2 | 7.4 | · | 7.8 | 7.5 | |
| P / Cash Flow | 88.8 | · | · | · | 185.2 | · | · | · | 125.9 | · | · | · | 115.8 | · | · | · | |
| P / FCF | 89.0 | · | · | · | · | · | · | · | 125.9 | · | · | · | 115.9 | · | · | · | |
| Earnings Yield | 4.9% | · | 2.9% | 1.6% | 1.7% | · | 1.9% | 1.9% | 2.6% | · | 2.4% | 2.6% | 1.5% | · | 1.9% | 2.1% |
القوائم المالية قائمة الدخل، الميزانية العمومية، التدفقات النقدية — سنويًا، آخر 5 سنوات
قائمة الدخل
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| الإيرادات | $645M | $570M | $475M | $419M | $344M |
| هامش الربح الإجمالي % | 89.1% | 90.2% | 89.3% | 87.2% | 88.4% |
| هامش الربح التشغيلي % | 33.3% | 39.9% | 34.5% | 29.9% | 33.1% |
| صافي الدخل | $196M | $223M | $148M | $113M | $155M |
| EPS المخفف | $0.98 | $1.11 | $0.72 | $0.53 | $0.70 |
الميزانية العمومية
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| النسبة الحالية | 6.1 | 7.0 | 6.2 | 7.0 | 8.1 |
| النسبة السريعة | 2.3 | 2.2 | 1.3 | 1.9 | 1.7 |
التدفق النقدي
| 2026-03-31 | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 | |
|---|---|---|---|---|---|
| التدفق النقدي الحر | $326M | $273M | $184M | $178M | $125M |
مقاييسي قائمة المراقبة الشخصية الخاصة بك — صفوف مختارة من الأساسيات الكاملة
اختر المقاييس التي تهمك — انقر فوق علامة ➕ بجوار أي صف في الأساسيات الكاملة أعلاه.
يتم حفظ اختيارك ويتبعك عبر جميع الأسهم.
الملاك المؤسسيون (13F) 414 مقدمي إقرار · $2.4B إجمالي · حتى تاريخ 30 يونيو، 2026
المؤسسات التي تبلغ عن حيازتها لهذا السهم في نموذج SEC 13F ربع السنوي الخاص بها. المراكز الطويلة فقط؛ قد يظهر مقدم واحد مرتين لأرجل خيارات منفصلة. الأرجل الكبيرة المتعاكسة من خيارات البيع/الشراء تعكس عادةً صناعة السوق أو المخزون المتحوط، وليس القناعة الاتجاهية.
| مراكز جديدة | المراكز الخارجة | زيادة | انخفض | صافي التغير في الأسهم |
|---|---|---|---|---|
| 48 (-41 مقابل الربع السابق) | 98 (-13 مقابل الربع السابق) | 120 (-43 مقابل الربع السابق) | 145 (+19 مقابل الربع السابق) | +15.1M |
مقارنة بـ Q1 2026. المواعيد النهائية لتقديم إقرارات نموذج 13F لهيئة الأوراق المالية والبورصات (SEC) هي في غضون 45 يومًا من نهاية الربع بالإضافة إلى فترة سماح قصيرة للمقدمين المتأخرين — يتم تخطي الأرباع التي لا تزال ضمن هذه النافذة لصالح أحدث زوج تم الإبلاغ عنه بالكامل.
| مؤسسة | القيمة | الأسهم | % من 13F المتتبعة | النوع |
|---|---|---|---|---|
| VANGUARD GROUP INC | $541905238 | 12238149 | 22,65% | الأسهم |
| VANGUARD PORTFOLIO MANAGEMENT LLC | $132468433 | 6387099 | 5,54% | الأسهم |
| VANGUARD CAPITAL MANAGEMENT LLC | $123971960 | 5977433 | 5,18% | الأسهم |
| D. E. Shaw & Co., Inc. | $110154475 | 5311209 | 4,60% | الأسهم |
| TWO SIGMA INVESTMENTS, LP | $96385189 | 4647309 | 4,03% | الأسهم |
| STATE STREET CORP | $87334253 | 4210909 | 3,65% | الأسهم |
| GOLDMAN SACHS GROUP INC | $71150727 | 3430604 | 2,97% | الأسهم |
| GEODE CAPITAL MANAGEMENT, LLC | $68911316 | 3321980 | 2,88% | الأسهم |
| RENAISSANCE TECHNOLOGIES LLC | $59184680 | 2853649 | 2,47% | الأسهم |
| BNP PARIBAS FINANCIAL MARKETS | $55840936 | 2692427 | 2,33% | الأسهم |
| WELLINGTON MANAGEMENT GROUP LLP | $55407740 | 2671540 | 2,32% | الأسهم |
| Carmignac Gestion | $48861366 | 2355900 | 2,04% | الأسهم |
| Squarepoint Ops LLC | $45090336 | 2174076 | 1,88% | الأسهم |
| LOOMIS SAYLES & CO L P | $44354523 | 2138598 | 1,85% | الأسهم |
| MILLENNIUM MANAGEMENT LLC | $42902785 | 2068601 | 1,79% | الأسهم |
| NORGES BANK | $39178461 | 1889029 | 1,64% | الأسهم |
| Gotham Asset Management, LLC | $35523762 | 1712814 | 1,48% | الأسهم |
| Iron Triangle Partners LP | $30401231 | 686568 | 1,27% | الأسهم |
| Walleye Capital LLC | $29032972 | 1399854 | 1,21% | الأسهم |
| Qube Research & Technologies Ltd | $26585445 | 1281844 | 1,11% | الأسهم |
| HEALTHCARE OF ONTARIO PENSION PLAN TRUST FUND | $24081214 | 1161100 | 1,01% | الأسهم |
| FORT WASHINGTON INVESTMENT ADVISORS INC /OH/ | $21706360 | 1046594 | 0,91% | الأسهم |
| TUDOR INVESTMENT CORP ET AL | $21106040 | 1017649 | 0,88% | الأسهم |
| Swedbank AB | $20958994 | 1010559 | 0,88% | الأسهم |
| BANK OF AMERICA CORP /DE/ | $19149532 | 923314 | 0,80% | الأسهم |
| VANGUARD FIDUCIARY TRUST CO | $17517170 | 844608 | 0,73% | الأسهم |
| ALGERT GLOBAL LLC | $16161002 | 779219 | 0,68% | الأسهم |
| BANK OF NOVA SCOTIA | $15850607 | 764253 | 0,66% | الأسهم |
| CANADA PENSION PLAN INVESTMENT BOARD | $14559480 | 702000 | 0,61% | الأسهم |
| Fundsmith LLP | $13549940 | 653324 | 0,57% | الأسهم |
| JANE STREET GROUP, LLC | $12967830 | 625257 | 0,54% | الأسهم |
| Voleon Capital Management LP | $12660816 | 610454 | 0,53% | الأسهم |
| CAPITAL FUND MANAGEMENT S.A. | $12189354 | 587722 | 0,51% | الأسهم |
| ING GROEP NV | $11890242 | 573300 | 0,50% | الأسهم |
| Wilmington Savings Fund Society, FSB | $11749210 | 566500 | 0,49% | الأسهم |
| DIMENSIONAL FUND ADVISORS LP | $11587957 | 558725 | 0,48% | الأسهم |
| BlackRock, Inc. | $9206880 | 443919 | 0,38% | الأسهم |
| PEAK6 LLC | $9123526 | 439900 | 0,38% | عقد خيار البيع |
| Swiss Life Asset Management Ltd | $8926309 | 430391 | 0,37% | الأسهم |
| CITADEL ADVISORS LLC | $8917018 | 429943 | 0,37% | الأسهم |
| CITADEL ADVISORS LLC | $8407996 | 405400 | 0,35% | عقد خيار البيع |
| RICE HALL JAMES & ASSOCIATES, LLC | $8187737 | 394780 | 0,34% | الأسهم |
| Emergence GP Partners, LLC | $8036750 | 387500 | 0,34% | الأسهم |
| Trexquant Investment LP | $7826115 | 377344 | 0,33% | الأسهم |
| Clearbridge Investments, LLC | $7727143 | 372572 | 0,32% | الأسهم |
| Retirement Systems of Alabama | $7339202 | 353867 | 0,31% | الأسهم |
| WOLVERINE TRADING, LLC | $6880992 | 91600 | 0,29% | عقد خيار الشراء |
| RHUMBLINE ADVISERS | $6703889 | 323237 | 0,28% | الأسهم |
| Liontrust Investment Partners LLP | $6465057 | 146004 | 0,27% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6412808 | 309200 | 0,27% | عقد خيار الشراء |
| BARCLAYS PLC | $6268645 | 302249 | 0,26% | الأسهم |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | $6222000 | 300000 | 0,26% | عقد خيار البيع |
| M&G PLC | $6171900 | 293900 | 0,26% | الأسهم |
| California Public Employees Retirement System | $6126679 | 295404 | 0,26% | الأسهم |
| Engineers Gate Manager LP | $5915007 | 285198 | 0,25% | الأسهم |
| RIVERBRIDGE PARTNERS LLC | $5832474 | 281219 | 0,24% | الأسهم |
| CITADEL ADVISORS LLC | $5635058 | 271700 | 0,24% | عقد خيار الشراء |
| Edgestream Partners, L.P. | $5545917 | 267402 | 0,23% | الأسهم |
| JANE STREET GROUP, LLC | $5330180 | 257000 | 0,22% | عقد خيار البيع |
| Swiss National Bank | $5012858 | 241700 | 0,21% | الأسهم |
| OMERS ADMINISTRATION Corp | $4942176 | 238292 | 0,21% | الأسهم |
| Man Group plc | $4865874 | 234613 | 0,20% | الأسهم |
| EFG Asset Management (North America) Corp. | $4717796 | 64486 | 0,20% | الأسهم |
| NATIXIS | $4528351 | 218339 | 0,19% | الأسهم |
| WOLVERINE TRADING, LLC | $4484664 | 59700 | 0,19% | عقد خيار البيع |
| VOYA INVESTMENT MANAGEMENT LLC | $4243777 | 204618 | 0,18% | الأسهم |
| WHITTIER TRUST CO | $4068486 | 177974 | 0,17% | الأسهم |
| VICTORY CAPITAL MANAGEMENT INC | $4023207 | 193983 | 0,17% | الأسهم |
| Brevan Howard Capital Management LP | $3976314 | 191722 | 0,17% | الأسهم |
| Quantbot Technologies LP | $3776630 | 182094 | 0,16% | الأسهم |
| ALLIANCEBERNSTEIN L.P. | $3708195 | 159150 | 0,15% | الأسهم |
| AXQ CAPITAL, LP | $3671893 | 177044 | 0,15% | الأسهم |
| CAXTON ASSOCIATES LLP | $3527584 | 170086 | 0,15% | الأسهم |
| Mitsubishi UFJ Trust & Banking Corp | $3509291 | 169204 | 0,15% | الأسهم |
| CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM | $3355223 | 144001 | 0,14% | الأسهم |
| BAILLIE GIFFORD & CO | $3350879 | 161566 | 0,14% | الأسهم |
| Y-Intercept (Hong Kong) Ltd | $3266114 | 157479 | 0,14% | الأسهم |
| Point72 Asset Management, L.P. | $3169072 | 152800 | 0,13% | عقد خيار البيع |
| Cresset Asset Management, LLC | $3149307 | 151847 | 0,13% | الأسهم |
| WORLDQUANT MILLENNIUM ADVISORS LLC | $2980836 | 143724 | 0,12% | الأسهم |
| Bridgewater Associates, LP | $2726211 | 131447 | 0,11% | الأسهم |
| LAZARD ASSET MANAGEMENT LLC | $2722001 | 131244 | 0,11% | الأسهم |
| Sparta 24 Ltd. | $2618757 | 126266 | 0,11% | الأسهم |
| VIRGINIA RETIREMENT SYSTEMS ET Al | $2574129 | 58133 | 0,11% | الأسهم |
| VANGUARD ASSET MANAGEMENT, Ltd | $2422266 | 116792 | 0,10% | الأسهم |
| Odyssean, LLC | $2376597 | 114590 | 0,10% | الأسهم |
| JANE STREET GROUP, LLC | $2345694 | 113100 | 0,10% | عقد خيار الشراء |
| STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM | $2257777 | 108861 | 0,09% | الأسهم |
| Schonfeld Strategic Advisors LLC | $2238819 | 107947 | 0,09% | الأسهم |
| AMERIPRISE FINANCIAL INC | $2224759 | 107269 | 0,09% | الأسهم |
| EFG Asset Management (Americas) Corp. | $2176286 | 29751 | 0,09% | الأسهم |
| WHITTIER TRUST CO OF NEVADA INC | $2136946 | 93973 | 0,09% | الأسهم |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | $2117224 | 90868 | 0,09% | الأسهم |
| CHILTON INVESTMENT CO INC. | $2090447 | 100793 | 0,09% | الأسهم |
| MACKENZIE FINANCIAL CORP | $2070080 | 99811 | 0,09% | الأسهم |
| Point72 Asset Management, L.P. | $2020076 | 97400 | 0,08% | عقد خيار الشراء |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | $2015596 | 97184 | 0,08% | الأسهم |
| Quantinno Capital Management LP | $1925356 | 92833 | 0,08% | الأسهم |
| XTX Topco Ltd | $1875249 | 90417 | 0,08% | الأسهم |
| Numerai GP LLC | $1833043 | 88382 | 0,08% | الأسهم |
المطلعون على الشركة 8 من المطلعين · مسؤولون 0 · مديرون 2
| مطلع | الدور | آخر نشاط | الأسهم المملوكة | مشتريات 12 شهرًا | مبيعات 12 شهرًا | صافي 12 شهرًا |
|---|---|---|---|---|---|---|
| Regina M. Benjamin | مدير | 13 يوليو، 2026 A | 50903 | 0 | 0 | $0 |
| Kevin Spain | مدير | 28 أغسطس، 2025 A | 9581 | 0 | 0 | $0 |
| Matthew Sonefeldt | — | 15 أغسطس، 2026 F | 486238 | 0 | 0 | $0 |
| Jeffrey Tangney | — | 15 أغسطس، 2026 F | 2531955 | 0 | 0 | $0 |
| Steven L Zatz | — | 15 أغسطس، 2026 F | 51864 | 0 | 0 | $0 |
| Siddharth Sitaram | — | 13 أغسطس، 2026 C | 93122 | 0 | 3 | $-132165 |
| Timothy S Cabral | — | 7 أغسطس، 2026 C | 3221 | 0 | 1 | $-293325 |
| Gilbert H Kliman | — | 2 أغسطس، 2022 D | 449960 | 0 | 0 | $0 |
المطلعون من إيداعات SEC Form 3/4/5؛ صافي = سوق مفتوح فقط
ملكية صناديق المؤشرات المتداولة محتفظ بها بواسطة 95 صناديق مؤشرات متداولة
الوزن يعكس فقط ممتلكات الأسهم المباشرة (N-PORT)؛ قد تحتفظ الصناديق المضاعفة أو القائمة على المشتقات بتعرض إضافي للمقايضة غير معروض.
| صندوق | الوزن | الوحدات | حتى تاريخ | المصدر |
|---|---|---|---|---|
| HEAL · Global X Funds | 2,56% | 29929 NS | 31 مايو، 2026 | N-PORT |
| GRPM · Invesco Exchange-Traded Fund Trust | 1,86% | 344667 SH | 8 أغسطس، 2026 | يومي |
| SMLL · Harbor ETF Trust | 1,54% | 8705 NS | 30 إبريل، 2026 | N-PORT |
| MCOW · Pacer Funds Trust | 1,30% | 523 NS | 30 إبريل، 2026 | N-PORT |
| XMHQ · Invesco Exchange-Traded Fund Trust | 0,60% | 1237748 SH | 8 أغسطس، 2026 | يومي |
| BUL · Pacer Funds Trust | 0,57% | 29427 NS | 30 إبريل، 2026 | N-PORT |
| IHF · iShares Trust | 0,41% | 245900 SH | 8 أغسطس، 2026 | يومي |
| COWG · Pacer Funds Trust | 0,39% | 349637 NS | 30 إبريل، 2026 | N-PORT |
| RFG · Invesco Exchange-Traded Fund Trust | 0,39% | 51157 SH | 8 أغسطس، 2026 | يومي |
| CALF · Pacer Funds Trust | 0,35% | 493056 NS | 30 إبريل، 2026 | N-PORT |
| AFMC · First Trust Exchange-Traded Fund VI… | 0,31% | 23780 NS | 31 مايو، 2026 | N-PORT |
| ESUM · Strategy Shares | 0,23% | 14226 NS | 30 إبريل، 2026 | N-PORT |
| FLOW · Global X Funds | 0,22% | 3006 NS | 31 مايو، 2026 | N-PORT |
| TMFX · RBB Fund, Inc. | 0,19% | 2892 NS | 31 مايو، 2026 | N-PORT |
| IVOG · VANGUARD ADMIRAL FUNDS | 0,15% | 132035 SH | 8 أغسطس، 2026 | يومي |
| IJK · iShares Trust | 0,15% | 783542 SH | 8 أغسطس، 2026 | يومي |
| EWUS · iShares Trust | 0,13% | 50934 SH | 8 أغسطس، 2026 | يومي |
| JPME · J.P. Morgan Exchange-Traded Fund Tr… | 0,13% | 22602 NS | 30 إبريل، 2026 | N-PORT |
| EQAL · Invesco Exchange-Traded Fund Trust … | 0,12% | 36369 SH | 8 أغسطس، 2026 | يومي |
| QVMM · Invesco Exchange-Traded Fund Trust … | 0,12% | 18788 SH | 8 أغسطس، 2026 | يومي |
| MIDE · DBX ETF Trust | 0,12% | 181 NS | 29 مايو، 2026 | N-PORT |
| VFQY · VANGUARD WELLINGTON FUND | 0,11% | 25965 SH | 8 أغسطس، 2026 | يومي |
| FSMD · FIDELITY COVINGTON TRUST | 0,10% | 94886 NS | 30 إبريل، 2026 | N-PORT |
| PTMC · Pacer Funds Trust | 0,10% | 15292 NS | 30 إبريل، 2026 | N-PORT |
| XJH · iShares Trust | 0,09% | 18212 SH | 8 أغسطس، 2026 | يومي |
| ISCG · iShares Trust | 0,08% | 39099 SH | 8 أغسطس، 2026 | يومي |
| IVOO · VANGUARD ADMIRAL FUNDS | 0,08% | 215901 SH | 8 أغسطس، 2026 | يومي |
| SMDX · Tidal Trust III | 0,08% | 3911 NS | 30 إبريل، 2026 | N-PORT |
| IJH · iShares Trust | 0,08% | 4616253 SH | 8 أغسطس، 2026 | يومي |
| BKMC · BNY Mellon ETF Trust | 0,07% | 18267 NS | 30 إبريل، 2026 | N-PORT |
| VBK · VANGUARD INDEX FUNDS | 0,07% | 1747294 SH | 8 أغسطس، 2026 | يومي |
| MIDU · Direxion Shares ETF Trust | 0,06% | 2216 NS | 30 إبريل، 2026 | N-PORT |
| BBMC · J.P. Morgan Exchange-Traded Fund Tr… | 0,06% | 52692 NS | 30 إبريل، 2026 | N-PORT |
| MVV · ProShares Trust | 0,06% | 4626 NS | 31 مايو، 2026 | N-PORT |
| JSTC · Tidal Trust I | 0,06% | 9533 NS | 31 مايو، 2026 | N-PORT |
| SCHA · SCHWAB STRATEGIC TRUST | 0,06% | 640841 NS | 31 مايو، 2026 | N-PORT |
| PRFZ · Invesco Exchange-Traded Fund Trust | 0,05% | 56967 SH | 8 أغسطس، 2026 | يومي |
| SCHM · SCHWAB STRATEGIC TRUST | 0,05% | 361328 NS | 31 مايو، 2026 | N-PORT |
| ESML · iShares Trust | 0,05% | 70407 SH | 8 أغسطس، 2026 | يومي |
| VFVA · VANGUARD WELLINGTON FUND | 0,05% | 21465 SH | 8 أغسطس، 2026 | يومي |
| SMLF · iShares Trust | 0,05% | 102257 SH | 8 أغسطس، 2026 | يومي |
| FHLC · FIDELITY COVINGTON TRUST | 0,05% | 57862 NS | 30 إبريل، 2026 | N-PORT |
| IYH · iShares Trust | 0,04% | 79278 SH | 8 أغسطس، 2026 | يومي |
| UMDD · ProShares Trust | 0,04% | 646 NS | 31 مايو، 2026 | N-PORT |
| IEUS · iShares Trust | 0,04% | 68778 SH | 8 أغسطس، 2026 | يومي |
| VHT · VANGUARD WORLD FUND | 0,04% | 362894 SH | 8 أغسطس، 2026 | يومي |
| ISCB · iShares Trust | 0,04% | 5498 SH | 8 أغسطس، 2026 | يومي |
| SMMD · iShares Trust | 0,04% | 65176 SH | 8 أغسطس، 2026 | يومي |
| RWK · Invesco Exchange-Traded Fund Trust … | 0,03% | 16664 SH | 8 أغسطس، 2026 | يومي |
| VXF · VANGUARD INDEX FUNDS | 0,03% | 1537722 SH | 8 أغسطس، 2026 | يومي |